Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2026-02-20 @ 6:43 PM
Study NCT ID:
NCT01773395
Status:
TERMINATED
Last Update Posted:
2022-07-18
First Post:
2013-01-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
GVAX vs. Placebo for MDS/AML After Allo HSCT
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01-08
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-24
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-08
First Submit QC Date:
None
Study First Post Date:
2013-01-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-12-07
Results First Submit QC Date:
None
Results First Post Date:
2022-03-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-30
Last Update Post Date:
2022-07-18
Last Update Post Date Type:
ACTUAL